-
'The Odyssey': Christopher Nolan's latest cultural phenomenon
-
US Federal Reserve expected to hold rates steady as inflation swirls
-
'Star Trek' celebrates 60th anniversary at Comic-Con
-
Merz vows justice after deadly car ramming near Berlin Gay Pride event
-
Merz vows justice after deadly car attack near Berlin Gay Pride event
-
Joshua survives knockdowns, stops Prenga
-
Merz vows justice after deadly car attack near Berlin Pride event
-
Ohtani delays throwing session over knee 'regression'
-
Hiltz extends US 1,500 streak, Lyles advances in 200
-
One killed, 15 wounded as car hits crowd near Berlin Gay Pride
-
'Difficult night' as France, Spain fires intensify again
-
Hodge, Hope give West Indies edge in rain-impacted Pakistan Test
-
Beaten Ramsay-Peaty casts doubt on future as Australia rule Commonwealth pool
-
Scheffler surges at 3M Open with blistering back nine
-
Ramsay-Peaty beaten into bronze as Australia's Williamson wins Commonwealth gold
-
Brazil's right-wing party nominates Bolsonaro son to battle Lula
-
Kazakh leader tells Putin war should end, Ukraine launches fresh strikes
-
Norris back on pole at Hungarian GP as rivals handed penalties
-
Madeleine McCann's brother targets Olympic dream after Commonwealth final
-
Close to Madrid, those who escaped flames worry what is next
-
Hamilton, Antonelli stung by grid penalties at Hungarian GP
-
Messi can skip All-Star Game after grueling World Cup, says MLS
-
Scotland declares 'major' wildfire in Cairngorms national park
-
Hamilton stung by three-place grid penalty
-
Spain fights to 'save lives' as wildfire evacuees shelter in Madrid
-
Howe uncertain if Guimaraes will stay with Newcastle amid Arsenal interest
-
Palestinians bury four killed in West Bank clash with Israeli settlers
-
Varane concussions motivate Como to ban heading in academy teams
-
49ers coach Shanahan injured in car crash
-
'Amazing' Pogacar-Del Toro friendship lights up Tour de France
-
China evacuates 340,000 people as Typhoon Noul approaches
-
Crisis-hit Flavio Bolsonaro launches presidential candidacy in Brazil
-
Norris back on pole for Mercedes at Hungarian GP
-
As wildfires grip France and Spain, what are the risks from the smoke?
-
Ukraine strikes Siberia refinery as Kazakh leader tells Putin war should end
-
Pogacar set to win Tour de France, Carapaz claims Queen stage
-
Kishan, Varma hit half centuries as India win Zimbabwe T20 series
-
India's education minister resigns, end called to Delhi protests
-
Houthis target Saudi oil as new Middle East front
-
Devastating wildfires send 267,000 fleeing in France and Spain
-
Madeleine McCann's brother reaches Commonwealth Games final
-
Ipswich sign Japan forward Maeda from Celtic
-
Thousands sheltered in Bordeaux as France wildfires trigger exodus
-
Norris finds pace to edge Hamilton in last Hungarian practice
-
Houthis say hit Saudi Arabia as fighting spreads on new Middle East front
-
China evacuates 20,000 people as Typhoon Noul nears
-
Untamed wildfires in Spain, France force over 200,000 to flee
-
Man City's Khusanov signs new five-year contract
-
Spain fights to 'save lives' as wildfires rage near Madrid
-
Atletico complete Lee signing from PSG
First person vaccinated during trial of new Ebola jab
A volunteer was injected on Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo, Oxford University said.
More than 1,000 people have been killed in the DRC and Uganda since the outbreak emerged in May, according to the World Health Organization.
Researchers and health organisations have since been racing to get a vaccine or treatment for the relatively rare strain to the clinical trial stage where it is tested on humans.
Earlier this month, a team at Oxford University in the UK announced it was launching the first trial for its ChAdOx1 BDBV vaccine, which uses the same technology as AstraZeneca's Covid-19 vaccine.
The first dose was administered to a 37-year-old volunteer named Ed Hunt in Oxford on Friday, a university spokesman told AFP.
"We've taken this vaccine candidate from concept to clinic in just eight weeks," David Pulido-Gomez of Oxford's Pandemic Sciences Institute said in a statement.
"Reaching this milestone in such a short timeframe reflects an extraordinary collaborative effort," he added.
The trial received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), while the Serum Institute of India has already manufactured a stockpile of 620,000 doses.
The phase 1 trial plans to assess the safety and effectiveness of the vaccine in 50 health adults in the coming weeks. The researchers are currently recruiting more volunteers.
Given regulatory approval, the team is preparing for more clinical studies of the vaccine with partners in Uganda, Oxford said.
Several other Bundibugyo vaccine candidates are also being urgently developed towards the trial stage, while two potential treatments are being worked on.
The Ebola outbreak is the 17th in the DRC's history, but just the third caused by the Bundibugyo strain, for which there are no approved vaccines or treatments.
WHO chief Tedros Adhanom Ghebreyesus warned last week that the outbreak had over the past month "expanded faster than any previous outbreak" of Ebola.
The outbreak has remained concentrated in the vast country's mineral-rich and conflict-plagued northeastern province.
Cases of Ebola, which spreads through close contact and infected bodily fluids, have also been found in four other DRC provinces.
S.Caetano--PC